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Abstract  
Context: To improve access to palliative care, identification of patients in need of general or 
specialized palliative care is necessary. To our knowledge, no available identification 
instrument makes this distinction. ID-PALL is a screening instrument developed to 
differentiate between these patient groups.  
Objective: To assess the structural and criterion validity and the inter-rater agreement of ID-
PALL. 
Methods: In this multicenter, prospective, cross-sectional study, nurses and physicians 
assessed medical patients hospitalized for 2 to 5 days in two tertiary hospitals in Switzerland 
using ID-PALL. For the criterion validity, these assessments were compared to a clinical gold 
standard evaluation performed by palliative care specialists. Structural validity, internal 
consistency and inter-rater agreement were assessed. 
Results: 2232 patients were assessed between January and December 2018, 97% by 
nurses and 50% by physicians. The variances for ID-PALL G and S are explained by two 
factors, the first one explaining most of the variance in both cases. For ID-PALL G, sensitivity 
ranged between 0.80 and 0.87 and specificity between 0.56 and 0.59. ID-PALL S sensitivity 
ranged between 0.82 and 0.94, and specificity between 0.35 and 0.64. A cut-off value of 1 
delivered the optimal values for patient identification. Cronbach’s alpha was 0.78 for ID-PALL 
G and 0.67 for ID-PALL S. The agreement rate between nurses and physicians was 71.5% 
for ID-PALL G and 64.6% for ID-PALL S. 
Conclusion: ID-PALL is a promising screening instrument allowing the early identification of 
patients in need of general or specialized palliative care. It can be used by nurses and 
         
physicians without a specialized palliative care training. Further testing of the finalized clinical 
version appears warranted. 
Key message 
This multicenter study demonstrates structural and criterion validity of ID-PALL, a new brief 
instrument for the interprofessional identification of patients in need of both general and 
specialized palliative care. 
Keywords  
Psychometrics, sensitivity and specificity, ID-PALL, palliative medicine, nurses, physicians. 
Running title 
ID-PALL: a screening tool for palliative care 
 
Introduction 
Depending on care settings, illnesses, co-morbidities and frailty, reported prevalence of 
palliative care patients varies between 7% and 73%. Despite the development of palliative 
care worldwide, access remains limited, especially for non-cancer patients, older people, and 
vulnerable and cultural minority patients (1-4). It is an ethical obligation to provide palliative 
care access to all patients irrespective of their diagnoses (5). International recommendations 
emphasize the necessity for systematic identification of patients’ palliative care needs in 
order to ensure equitable access to care and promote social justice (5, 6). Although the 
World Health Organization (WHO) definition clarifies the concept of palliative care (7), it does 
not make the distinction between general and specialized palliative care needs (8). General 
palliative care refers to patients with a life-threatening prognosis of a chronic, progressive, 
incurable and life-threatening disease, or who have reached the end of their life, without 
complex problems. About 75% to 80% of all palliative care patients do not have complex 
needs and thus do not require specialists in palliative care (8-10). The remaining 20% to 25% 
of palliative care patients have complex needs, including unstable clinical conditions, 
         
unpredictability and/or high level of bio-psycho-socio-existential suffering, requiring specific 
treatment (11, 12). Although the distinction is being made between generalized and 
specialized palliative care, there is still significant debate about where these thresholds lie. 
For the moment, in clinical practice, this distinction is relatively arbitrary and subject to 
misinterpretation (8, 11, 13). However, appropriate differentiation between these patient 
groups is pre-requisite for adequate delivery of palliative care (14, 15). 
Instruments for the identification of palliative care patients are mostly screening checklists 
(16-18). The purpose of a screening test is to estimate the likelihood of having the condition 
being screened (19, 20). Diagnostic tests, on the other hand, make it possible to detect or 
exclude a pathology in a patient (21). Screening instruments should encourage discussion 
among professionals about what decision to make, be inexpensive and easy to use (21). For 
a screening instrument, it is recommended to maximize sensitivity to avoid missing patients 
with the condition (true positives) (21-23).  
A number of instruments to identify patients in need of palliative care are available. In a 
recent systematic review (24, 25) we found four instruments designed for hospital use, 
namely the CAPC (26), the NECPAL (27), the PCST (28) and the SPICT (29). None 
exhibited sufficiently valid psychometric measurement properties according to the COSMIN 
criteria (30). Criterion validity, when assessed, was based on mortality prediction (31-34), 
which is incongruent with the concept of early integration of palliative care (16). Finally, none 
of these instruments differentiates between patients in need of general versus specialized 
palliative care (16, 35).  
To fill in this gap, we developed ID-PALL© (IDentification of patients in need of PALLiative 
care) a new screening instrument developed as a clinician-reported outcome measure (for 
details of the instrument development, see ref. 36). ID-PALL does not require detailed 
medical information and can be used by nurses and physicians alike based on their clinical 
observations. The content and face validity were deemed to be acceptable by both the expert 
         
and the target population (36). The aim of this study was to assess the structural validity, the 
criterion validity and the inter rater agreement of ID-PALL.  
Methods 
Study setting 
This multicenter, prospective and cross-sectional study was conducted in the French and 
Italian linguistic regions of Switzerland. To obtain a homogenous sample, it was carried out in 
seven internal medicine units: four in a university French-speaking hospital and three in a 
community Italian-speaking hospital, for a total of 190 beds. Both hospitals have a dedicated 
inpatient palliative care unit and a palliative care hospital support team. 
Instrument 
ID-PALL includes two parts: part one (seven items) to identify patients requiring general 
palliative care (ID-PALL G) and part two (eight items) to identify patients requiring specialized 
palliative care (ID-PALL S). Hereinafter, the name ID-PALL refers to the total item list used 
for the validation process. Items assess important aspects of palliative care, such as 
presence of a progressive illness, cessation of life-sustaining treatment, and psychosocial or 
existential distress of patients or relatives. The level of complexity distinguishes the two 
parts. ID-PALL S is only completed if ID-PALL G is positive. Each item is rated based on a 
structured “yes/ no” response format. In each part, one positive response to any item was 
considered as the cut-off to require either general or specialized palliative care. Nurses and 
physicians were instructed to fill in the instrument based on their clinical observations, 
anamnesis and when possible the patient’s self-assessment. 
Specific written recommendations were developed for patients requiring general palliative 
care, for the benefit of non-specialized healthcare professionals caring for the patients. Their 
acceptance and impact will be assessed in a separate study.  
 
 
         
Ethical considerations 
Due to the sensitive nature of the study topic, the local Human Research Ethics Committee 
stipulated that ID-PALL had to be used by mixing all the items, rather than in its definitive 
two-part format, so as not to influence clinical practice. Thus, healthcare professionals 
completing ID-PALL were unaware of its original structure. Two regional human research 
ethics committees approved this study on November 6, 2017. 
Structural validity  
Structural validity was tested separately for ID-PALL G and ID-PALL-S. The Kaiser–Meyer–
Olkin (KMO) measure of sampling adequacy (which may vary between 0 [no adequacy] and 
1 [maximal adequacy]; a value of 0.6 is generally accepted as sufficient) and Bartlett’s test of 
sphericity (a measure of the correlation matrix between the items) were used to assess the 
suitability of the data for an exploratory factorial analysis (EFA). The internal factor structure 
of ID-PALL G and ID-PALL S was tested with a principal component analysis using varimax 
rotation. Eigenvalues higher than one were used to verify factor solution accuracy (Kaiser 
criterion). Confirmatory factor analysis (CFA) is recommended in order to obtain a ‘very good’ 
COSMIN rating. However, an EFA is rated as “adequate” (30). In order to keep only the 
factors with the greatest variance, we have retained those with an eigenvalue ≥1. 
Internal consistency 
According to COSMIN recommendations, we calculated Cronbach’s alpha. Sufficient internal 
consistency is assumed for Cronbach’s alpha ≥ 0.70 (30).  
Criterion validity  
Criterion validity evaluates the extent to which the assessed measurement is associated with 
a recognized external criterion, or gold standard (37, 38). However, “this is a challenging 
concept for health care services that are not disease-based, such as palliative care” (39). In 
the absence of a recognized gold standard, the use of expert clinical assessment is the best 
alternative (40). Consequently, and in line with the interprofessional approach of the 
         
discipline, we have considered the combined clinical judgment of a physician-nurse dyad, 
both specialized in palliative care, as the “clinical gold standard”. Its role was to classify the 
patients into one of the following categories: not requiring palliative care, requiring general 
palliative care, or requiring specialized palliative care.  
Participants and selection criteria 
 Primary care nurses and physicians of the participating internal medicine units completed 
ID-PALL. No demographic information other than profession was collected.  
 Experienced nurses and physicians as clinical gold standard were to have completed a 
specialist palliative care training and to have at least three years of clinical work 
experience in a specialized palliative care setting. 
 Screened patients were over 18 years and hospitalized for between 2 and 5 days in the 
participating units between January and December 2018. Patients already referred to the 
palliative care hospital support team were excluded. 
Procedure 
Evaluation of the clinical gold standard 
At the community hospital, the clinical gold standard performed their assessment based on 
the weekly palliative care liaison rounds and the computer-based patient record. At the 
university hospital, where palliative care liaison rounds are not currently in place, assessment 
was based on detailed examination of the computer-based patient record. All clinical gold 
standards were blinded to the results of the ID-PALL assessment by the primary care nurses 
and physicians.  
Evaluation based on ID-PALL 
Primary care nurses assessed all patients meeting the study criteria at both sites. Twice a 
week, the research team gave the nurses an ID-PALL form with the name of the patients to 
be evaluated. 
 
         
Statistical analyses and sample size calculation 
We used Area Under the receiver operator Curve (AUC) analysis to show the screening 
ability of ID-PALL G in identifying general palliative care patients against non-palliative care 
patients, and of ID-PALL S in identifying specialized palliative care patients against general 
palliative care patients. For evidence of good measurement properties, the AUC should be ≥ 
0.70 (30). We also calculated the sensitivity, specificity, and the positive and negative 
predictive values (PPV and NPV) for different cut-off scores.  
The sample size was calculated according to the prevalence of patients in need of general or 
specialized palliative care reported in the literature (around 35% for general palliative care 
and 7% for specialized palliative care in internal medicine units) (41, 42).The sensitivity 
threshold was set at 0.9 and the precision level at 5%. A sample size of 2000 patients was 
calculated in order to be able to identify at least 700 general palliative care patients. 
Considering our large sample, we chose to remove all assessments with missing data in 
order to avoid any misinterpretation. Data from the two sites did not show major differences 
and were pooled together. For the results by site, see supplementary material. 
Inter-rater agreement 
Because we assessed the agreement between nurses and physicians, the term inter-rater 
agreement appears to be more appropriate than inter-rater reliability. The two professions 
have complementary competences and different training backgrounds, thus differences in 
assessment are to be expected. Cohen’s kappa (0 = same concordance as that due to 
chance; 1 = perfect concordance) and percentage of agreement were calculated. 
Procedure  
To assess the inter-rater agreement, 85 general palliative patients needed to be assessed by 
nurses and physicians. This sample size was applied for both study sites. Thus, primary care 
physicians at the university hospital were involved in the last three months of data collection. 
At the community hospital, primary care physicians were involved in the assessment for the 
         
entire data collection time. Primary care nurses and physicians completed ID-PALL of the 
same patient on the same day on an individual ID-PALL form, independently, at both sites. 
Statistical analyses were carried out using SPSS 26. 
ID-PALL availability in different languages 
The instrument was tested in its original language (French) and in the translated Italian 
version. A standardized forward-backward translation process was used to translate the 
instrument in Italian, German and English (43) (see supplementary material for the English 
version).  
Results 
Recruitment and sample characteristics 
Between January and December 2018, 2232 of the 2479 patients (90%) who met the 
inclusion criteria were assessed with ID-PALL (1533 at the university hospital and 699 at the 
community hospital). Nurses assessed 97% of the included patients and physicians 50% 
(Figure 1). Mean age of the patients was 73 years (±16.5); 54% were men. Patients from the 
university hospital were significantly older than patients from the community hospital (75.3 vs 
71.2 yrs.). Patients had a large spectrum of pathologies, with a strong representation of 
chronic heart failure and cancer, which are distributed differently between the two hospitals 
(Table 1).  
Figure 1: Patient selection flow chart 
Insert Figure 1 here 
Table 1: Patients’ demographics and diagnoses 
Insert Table 1 here 
 
 
         
Structural validity 
For ID-PALL G, the KMO measure indicated a sampling adequacy of 0.834 and a Bartlett’s 
test of sphericity for the correlation between items at 2 = 3265.276 (p = .000). For ID-PALL 
G, the exploratory factor analysis with varimax rotation revealed two factors explaining 59% 
of the total variance for ID-PALL G with an eigenvalue higher than one (3.106 and 1.029). 
The first factor explained the greatest percentage of this variance (44% vs 15%).  
For ID-PALL S, the KMO measure indicated a sampling adequacy at .786 and a Bartlett’s 
test at 2 = 2437.381 (p = .000). The factorial analysis revealed two factors explaining 47% of 
the total variance for ID-PALL S with an eigenvalue higher than one (2.720 and 1.062). The 
first factor explained the greatest percentage of this variance (34% vs 13%). Correlations 
between items and each factor for ID-PALL G and S are shown in Table 2. 
Table 2: Correlations between items of the ID-PALLG and S and the two factors found by the 
principal component analysis with varimax rotation. 
Insert Table 2 here 
Internal consistency 
Cronbach’s alpha for ID-PALL G was 0.78 and for ID-PALL S 0.67. 
Criterion validity 
Figures 2 and 3 show receiver operating characteristic (ROC) curve analysis for the two 
parts of ID-PALL. Considering the nurses’ assessment, ID-PALL G has the ability to 
discriminate general palliative care patients from non-palliative care patients with an AUC of 
0.744 (CI: 0.721-0.766), while ID-PALL S has the ability to discriminate specialized palliative 
care patients from general palliative care patients with an AUC of 0.714 (0.666-0.762).  
Figure 2: ROC curve analysis for ID-PALL G 
Insert Figure 2 here 
         
Figure 3: ROC curve analysis for ID-PALL S 
Insert figure 3 here 
Tables 3 and 4 show the sensitivity, specificity, positive and negative predictive values for the 
various cut-off scores for ID-PALL G and ID-PALL S by considering the nurses’ 
assessments. In both cases, the cut-off value of 1 delivers the optimal values for patient 
identification.  
Table 3: ID-PALL G score cut-offs to identify general palliative care patients by nurses, N = 
1920 
Insert Table 3 here 
Table 4: ID-PALL S score cut-offs to identify specialized palliative care patients by nurses, 
N = 806 
Insert Table 4 here 
 
The score of 1 is also the best cut-off for the physicians when considering both the ID-PALL 
G and S. Regarding ID-PALL G, the results indicated an AUC of 0.768 (CI: 0.739-0.797), a 
sensitivity of 87.0%, a specificity of 55.7%, a PPV of 55.6%, and a NPV of 87.1%. Regarding 
ID-PALL S, the results showed an AUC of 0.633 (0.557-0.709), a sensitivity of 93.3%, 
specificity of 33.2%, a PPV of 17.9%, and a NPV of 97.0%. 
Inter-rater agreement 
Cohen's kappa was calculated on 877 patients for ID-PALL G and 478 for ID-PALL S. The 
results were 0.39 with an agreement rate of 70.5% for ID-PALL G and 0.21 with a 61.5% 
agreement for ID-PALL S.  
Discussion 
This multicenter study involving over 2200 patients is, to the best of our knowledge, the first 
to validate a screening instrument that distinguishes between general and specialized 
palliative care. Nurses on the wards were able to assess 97% of all patients meeting the 
study criteria, which demonstrates the feasibility of the assessment in clinical practice.  
         
Structural validity of ID-PALL 
While two factors explain 59% of the variance for ID-PALL G and 47% for ID-PALL S, the 
first factor explains the greater variance for both parts of the instrument. When observing the 
items presenting the highest correlations with the first factor, it is notable that they are 
characterized by a certain level of heterogeneity in terms of content, as detailed in Table 2. 
This variety of dimensions gathered under an overarching factor is in line with the pre-
established conceptualization of ID-PALL, which strived to encompass as much as possible 
the multidimensionality of palliative care. The results of the factor analysis led us not to apply 
specific dimensions in each of the two parts of the ID-PALL, but rather to consider all the 
items for an overall score. Thus, we used this overall score to assess the criterion validity of 
our instrument. 
When comparing our results with those of other instruments like the NECPAL (27) and the 
SPICT (29) which were designed for hospital use, it is worth mentioning that the underlying 
structure of these two instruments includes general health status criteria as well as specific 
criteria related to the underlying diagnoses. The latter criteria are not required to complete 
ID-PALL, in order to make it easier for nursing professionals to use it independently of 
physicians. 
According to our EFA results, we could consider removing items 5 (relatives’ psychosocial 
suffering) and 6 (palliative sedation) of ID-PALL. However, it seems essential to keep item 5 
to remain coherent with the definition of palliative care which includes patients and their 
relatives and which encourages psychosocial care for both. Item 6 may be considered 
redundant in light of items 1 (severe and persistent symptom) and 4 (severe psychosocial or 
existential suffering). As the EFA was conducted using the items in a mixed manner and not 
on the final version of the instrument, we chose to wait for the CFA which will be carried out 
on the final version of the instrument to determine whether or not to keep these items. 
 
         
Internal consistency 
According to the COSMIN criteria, the internal consistency of ID-PALL G is considered as a 
good measurement property. The internal consistency of ID-PALL S is slightly under this cut-
off and remains the same even if an item is removed. Our instrument is based on a formative 
model where the different items are heterogeneous with respect to the construct. This is 
different than a reflective model in which all items are a manifestation of the same underlying 
construct and are highly correlated (37). Thus, we are satisfied with the internal 
consistencies found for both ID-PALL parts. Our systematic review revealed that none of the 
included instruments had a measure of internal consistency, which does not allow for a 
comparison. 
Criterion validity of ID-PALL 
According to the COSMIN criteria, the correlation with the gold standard demonstrated good 
measurement properties for ID-PALL G and S. (30). For both parts of the instrument, we 
found the cutoff of 1 to be the optimal score when searching for an adequate balance 
between sensitivity and specificity. However, while the NPV appears good for both parts of 
the ID-PALL, the PPV is low for the ID-PALL G and very low for the ID-PALL S (55.8% and 
28.2%, respectively). Of note, these low PPV scores are coherent with other studies that 
have assessed the criterion validity of various screening instruments in palliative care (31, 
44, 45).  
In terms of sensitivity and specificity, ID-PALL values are quite similar to those reported for 
previously developed instruments concerning their ability to predict deaths at 12 months 
(NECPAL: sensitivity 0.91, specificity 0.32 (46); SPICT 0.84 and 0.58, respectively (47)). 
However, the use of mortality at 12 months as gold standard to assess the validity of these 
instruments represents a major limitation, since the clinical need for palliative care is 
evidently neither dependent on nor necessarily correlated with 12-month mortality (16).  
         
The choice of a cut-off at 1 aims at maximizing the sensitivity of the instrument (20), in order 
not to miss patients with palliative care needs and to provide them with the appropriate level 
of palliative care as early as possible in their illness trajectory. Moreover, preliminary 
observations from an ongoing feasibility study show that the systematic use of such an 
instrument for all admitted patients may represent an idealistic goal in acute hospital settings. 
Clinicians seem more likely to use ID-PALL to confirm or disprove their clinical hypotheses 
for each individual patient. We therefore recommend the use of ID-PALL as an instrument to 
support clinical decision making rather than a “classical” screening method (21, 48) 
According to the COSMIN recommendations and in the absence of a generally accepted 
gold standard, we have tested ID-PALL using a gold standard based on clinical assessment 
completed by a nurse and physician dyad specialized in palliative care (49). This choice 
reflects the fundamentally interprofessional nature of palliative care, and is in line with the 
aim of developing an instrument that can be used by nurses and physicians interchangeably.  
Inter-rater agreement 
The inter-rater agreement between nurses and physicians was low to moderate, and 
physicians tended to identify general palliative care patients slightly better than nurses. This 
may be due to medical training in Switzerland including mandatory teaching in palliative care, 
while this is optional in pre-graduate nursing training. In addition, a better knowledge of the 
medical diagnosis may still positively influence the ability to complete ID-PALL G. In order to 
base the assessment on a comprehensive knowledge of the patients and families. We 
encourage completing ID-PALL based on an interprofessional discussion. 
In total, three of the eight categories of the COSMIN criteria were tested in this study. To be 
in line with the COSMIN methodology, further tests will have to be carried out (e.g. 
measurement error, cross-cultural validity, responsiveness). Consistent with the development 
phase of ID-PALL, we began with an EFA. A CFA will be conducted as part of a feasibility 
study, which is currently underway. Because of the limits of the inter-rater measurement 
mentioned above, we plan to re-assess inter-rater reliability within each profession. In the 
         
future, it would also be interesting to test ID-PALL in comparison with other identification 
instruments measuring similar constructs. 
Strength and limitations 
The main strength of this study is its large sample size of over 2200 patients. One major 
limitation is that the clinical gold standard of the university hospital relied on electronic patient 
records, which often lacked information about social, psychological and spiritual aspects. In 
addition, due to the decision of the ethics committee, we had to perform the study using a list 
of mixed-up items instead of ID-PALL G and S in their final format. We can thus hypothesize 
that results may improve when professionals will use the instrument in its intended format, as 
filling in the individual items of the instrument without the understanding of its clinical logic 
may have complicated this process for the study participants. Finally, we could not collect 
demographic data from the participating professionals because it was requested from the 
medical and nursing heads that the collaborators not be identified in order to protect their 
confidentiality, maximize study participation and compliance with the research protocol. 
Conclusion  
ID-PALL is, to the best of our knowledge, the first screening instrument allowing the early 
identification of patients in need of general vs. specialized palliative care by nurses and 
physicians without a specialized palliative care training. The structural validity of the two 
parts of ID-PALL is good and the choice of a cut-off at 1 for both parts of the instrument is 
confirmed. We tested the criterion validity of ID-PALL against a clinical gold standard 
evaluation – a new approach for this kind of instruments. This multicenter study shows that 
ID-PALL is a promising instrument with sufficiently robust measurement properties to warrant 
further testing in a clinical implementation study, which is currently underway. 
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Patients included N = 2232 (90%) 
Patients screened by nurses n = 2161 (97%) 
Patients screened by physicians n = 1126 (50%) 
         





Figure 3: ROC curve analysis for ID-PALL S by nurses 
 
  
         














N (%) / 
mean (SD) 
n (%) / mean 
(SD) 
n (%) / mean 
(SD) 
  
Gender    .266 .606 
Women 1027 (46%) 711 (46%) 316 (45%)   
Men 1205 (54%) 822 (54%) 283 (55%)   
Age 73 (16.5) 71.2 (17) 75.3 (14.8) -5.511 .000 
Diagnosis      
Cancer 510 (23%) 392 (26%) 118 (17%)   
Dementia 201 (9%) 145 (10) 56 (8%)   
CHF 761 (34%) 447 (29%) 314 (45%)   
COPD 211 (9%) 148 (10%) 63 (9%)   
Renal diseases 98 (4%) 75 (5%) 23 (3%)   
Neurological 
disorders 
66 (3%) 46 (3%) 20 (3%)   
Metabolical 
disorders 
78 (4%) 50 (3%) 28 (4%)   
Gastrointestinal 
diseases 
94 (4%) 72 (5%) 22 (3%)   
Others 213 (10%) 158 (10%) 55 (8%)   
CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SD = standard deviation 
 
  
         
Table 2: Correlations between items of the ID-PALLG and S and the two factors found by the 
principal component analysis with varimax rotation 
                                                                                                                                    Factors 
ID-PALL G   
 
1 2 
Item 1 : surprise question .668 .164 
Item 2a : progressive illness or group of illnesses or comorbidities that 
limits their life expectancy and decline in general functioning 
.809 .097 
Item 2b : progressive illness or group of illnesses or comorbidities that 
limits their life expectancy and pronounced instability 
.794 .082 
Item 2c : progressive illness or group of illnesses or comorbidities that 
limits their life expectancy and psychosocial or existential suffering 
.633 .230 
Item 2d : progressive illness or group of illnesses or comorbidities that 
limits their life expectancy and the need for support 
.626 .340 
Item 3: current or planned interruption of treatments with curative 
intent or vital support measures 
.109 .843 
Item 4: request for comfort care or palliative care from the patient, 
people close to them or health professionals 
.243 .786 
ID-PALL S   
 1 2 
Item 1: presence of at least one severe and persistent symptom that has 
not responded satisfactorily to treatment within 48 hours. 
-.047 .769 
Item 2: difficulties in evaluating physical symptoms or psychological, 
social difficulties or spiritual distress:  
.758 .019 
Item 3 : disagreement or uncertainty on the part of the patient, people 
close to them or health professionals regarding 
.791 .085 
Item 4: the patient has severe psychosocial or existential suffering:  .580 .297 
Item 5 : people close to the patient experience severe psychosocial or 
existential suffering 
.198 .395 
Item 6 : palliative sedation is envisaged .383 .420 
Item 7 : advance care plan or advance directives are difficult to establish 
with the patient and/or people close to them 
.562 .353 
Item 8 : in your opinion, the patient, people close to them or health 





         
Table 3: ID-PALL G score cut-offs to identify general palliative care patients by nurses in total, N = 
1920 
IDPALL score 







≥ 1 80.1 58.5 61.3 78.2 
≥ 2 62.4 75.5 67.7 71.0 
≥ 3 45.7 85.1 71.6 65.6 
≥ 4 30.5 93.1 78.3 62.0 
≥ 5 17.8 97.3 84.6 59.1 
≥ 6 9.5 99.3 92.1 57.2 
≥ 7 3.8 99.7 91.7 55.8 
 
Table 4: ID-PALL S score cut-offs to identify general palliative care patients by nurses in total, N = 806 
IDPALL score 







≥ 1 82.4 63.6 14.9 97.9 
≥ 2 64.9 73.2 19.2 96.7 
≥ 3 47.3 88.5 24.2 95.6 
≥ 4 31.3 93.6 27.3 94.5 
≥ 5 16.8 96.5 27.2 93.8 
≥ 6 6.9 98.2 22.5 93.2 
≥ 7 4.6 99.2 30.0 93.1 
≥ 8 2.3 99.8 42.9 93.0 
 
 
         
